RECRUITING

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Description

The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) decision support (enhanced usual care + decision aid). Assessments will take place at baseline (T0) and 1-month post-intervention (T1). The primary outcome is informed decisions about breast MRI at T1.

Study Overview

Study Details

Study overview

The purpose of this study is to test the impact of a multilevel decision support intervention on informed decisions about breast MRI among high-risk Black and Latina women. Participants (N=80) will be randomized to (1) enhanced usual care (risk assessment + referral to nurse practitioner) or (2) decision support (enhanced usual care + decision aid). Assessments will take place at baseline (T0) and 1-month post-intervention (T1). The primary outcome is informed decisions about breast MRI at T1.

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

The FYI on MRI: A Multilevel Decision Support Intervention for Screening Breast MRI

Condition
Breast Neoplasm Female
Intervention / Treatment

-

Contacts and Locations

Washington D.C.

Georgetown University, Washington D.C., District of Columbia, United States, 20007

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * female
  • * aged 40-74 years
  • * self-identifying as Black and/or Latina
  • * no personal history of breast cancer
  • * English- or Spanish-speaking
  • * having received a mammogram through Ralph Lauren Center (RLC) navigation
  • * ≥20% lifetime breast cancer risk per the NCI Breast Cancer Risk Assessment Tool (BCRAT)
  • * aged \<40 or ≥75
  • * pregnancy

Ages Eligible for Study

40 Years to 74 Years

Sexes Eligible for Study

FEMALE

Accepts Healthy Volunteers

No

Collaborators and Investigators

Georgetown University,

Claire C. Conley, PhD, PRINCIPAL_INVESTIGATOR, Georgetown University

Study Record Dates

2027-12